From Immunization Action Coalition <[email protected]>
Subject IAC Express #1,598 – ACIP meeting today, CDC updates on COVID-19 boosters, and more.
Date November 3, 2021 10:01 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]

Issue 1,598: November 3, 2021

Top Stories
* Watch today (November 3 at 10:00 a.m. ET): ACIP meeting on hepatitis B, orthopoxvirus, Ebola vaccines, and immunization schedules; no registration required
* "The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines—United States, 2021" published in MMWR Early Release
* CDC updates interim clinical considerations for COVID-19 vaccines, including booster doses of Moderna and Janssen (Johnson & Johnson) vaccines
* COVID-19 vaccination provider webinars to explain new recommendations and products
* CDC updates orders regarding COVID-19 testing and vaccination of international travelers flying to the United States, effective November 8
* GlaxoSmithKline recalls one lot of pediatric hepatitis B vaccine pre-filled syringes for missing label on some syringes
* Keep up with influenza this season: CDC’s FluView surveillance reports now being posted weekly
* IAC Spotlight! IAC’s “Standing Orders Templates for Administering Vaccines” main page offers templates to facilitate vaccine delivery
* Journalists interview IAC experts
* Vaccines in the news
* Correction: IAC Express # 1,597 (October 27)

Immunize.org Pages and Handouts
* IAC updates four influenza-related, print-ready materials for patients and healthcare personnel
* Recap: These updated IAC materials for clinicians were released during September and October

Vaccine Information Statements
* Recap: These new VISs and VIS translations were released during September and October

Featured Resources
* Give thanks for COVID-19 vaccines this season! IAC offers FREE "I Got My COVID-19 Vaccine" buttons and stickers. Available in English and Spanish.
* Explore the updated www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations

#IACX16
Notable Publications
* "Laboratory-Confirmed COVID-19 among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity—Nine States, January–September 2021" published in MMWR Early Release
* MMWR Recap: “COVID-19 Vaccination and Non-COVID-19 Mortality Risk––Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021”
* CHOP's Vaccine Education Center publishes October issue of Vaccine Update newsletter

Global News
* “Routine Vaccination Coverage—Worldwide, 2020” published in MMWR

Upcoming Events
* Today! Virtual: CDC offers "Current Issues in Immunization Webinar" on recommendations for the 2021–22 influenza season on November 3
* Virtual: Vaccine Education Center’s Current Issues in Vaccines for Providers webinar on December 8 features Dr. Paul Offit discussing COVID-19 vaccine booster doses; CE available


------------------------------------------------------------
Top Stories
------------------------------------------------------------
=WATCH TODAY (NOVEMBER 3 AT 10:00 A.M. ET): ACIP MEETING ON HEPATITIS B, ORTHOPOXVIRUS, EBOLA VACCINES, AND IMMUNIZATION SCHEDULES; NO REGISTRATION REQUIRED=

CDC will convene its Advisory Committee on Immunization Practices (ACIP) ([link removed]) today, November 3, from 10:00 a.m.–5:00 p.m. (ET). The meeting will include ACIP votes on new recommendations for adult hepatitis B, orthopoxvirus, Ebola vaccines, and the 2022 immunization schedules.

[link removed]

No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.

View the agenda. ([link removed])

Related Links
* ACIP main page ([link removed]) for access to webcast, agendas
* ACIP Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings

------------------------------------------------------------
"The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines—United States, 2021" published in MMWR Early Release

CDC published The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines—United States, 202 ([link removed]) 1 on October 29 as an MMWR Early Release. A portion of the summary appears below.

In the United States, three COVID-19 vaccines are approved or authorized for primary vaccination against COVID-19....The [ACIP] issued recommendations for an additional primary mRNA COVID-19 vaccine dose for immunocompromised persons and a COVID-19 vaccine booster dose in eligible groups.

Access the MMWR Early Release article in HTML ([link removed]) or PDF ([link removed]) .

Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications

------------------------------------------------------------
CDC updates interim clinical considerations for COVID-19 vaccines, including booster doses of Moderna and Janssen (Johnson & Johnson) vaccines

CDC updated their Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States ([link removed]) on October 25. This guidance provides additional information for healthcare providers and public health officials on use of COVID-19 vaccines. All healthcare professionals administering or counseling patients on COVID-19 vaccination should review all changes on the web page.

CDC summarized the October 25 changes as follows:
* Updated guidance in section on Considerations for use of a COVID-19 booster dose ([link removed])
* New section added on Overview of COVID-19 vaccines recommendations ([link removed])
* Updated guidance in section on COVID-19 vaccine dosage and schedule ([link removed])
* Updated guidance in section on People vaccinated for prevention of COVID-19 outside the United States ([link removed])
* Updated guidance in section on COVID-19 vaccination and SARS-CoV-2 infection ([link removed]) for People with prior or current SARS-CoV-2 infection; People with a history of multisystem inflammatory syndrome in children (MIS-C) or adults (MIS-A); People who received passive antibody products; and Vaccinated people who subsequently develop COVID-19
* New guidance on Considerations for COVID-19 revaccination in the section on Considerations for COVID-19 vaccination in moderately and severely immunocompromised people ([link removed])
* Updated Table in Appendix A: Vaccine administration errors and deviations ([link removed])

View the CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States ([link removed]) web page.

Related Links
* CDC: Summary Document for Interim Clinical Considerations ([link removed]) [link removed](PDF)
* CDC: Summary Document for Interim Clinical Considerations poster ([link removed]) (PDF)
* CDC: COVID-19 Vaccine Administration Errors and Deviations ([link removed]) (PDF)
* CDC: COVID-19 Vaccine Administration Errors and Deviations poster ([link removed]) (PDF)
* IAC: Vaccines: COVID-19 ([link removed]) main page
* IAC: Ask the Experts: COVID-19 ([link removed]) web page


------------------------------------------------------------
COVID-19 vaccination provider webinars to explain new recommendations and products

Pfizer-BioNTech and Moderna are offering new educational webinars open to all COVID-19 vaccination providers regarding new recommendations and products. Janssen (Johnson & Johnson) Vaccine informational materials online also have been updated. Details are listed below:

Pfizer-BioNTech

Pfizer-BioNTech U.S. Medical Affairs is hosting a webinar titled "Immunization Site Training Sessions for All Providers on the Storage, Handling, & Administration for Current & Potential New Formulations." Webinar dates and times are as follows:
* November 3 at 12:00 p.m. (ET) ([link removed]) – Password: 82qdN3PppPp
* November 4 at 12:00 p.m. (ET) ([link removed]) – Password: Y4ZkXdh2bz7
* November 5 at 12:00 p.m. (ET) ([link removed]) – Password: rJSpNPts332

These Pfizer-BioNTech COVID-19 vaccine educational materials and web pages have been updated:
* CDC: Clinical guidance and vaccine information for Pfizer-BioNTech COVID-19 Vaccine ([link removed])
* FDA: Main page leading to Fact Sheets for Healthcare Providers and Fact Sheets for Recipients and Caregivers, specific to either age 5 through 11 years or age 12 and older ([link removed]) (PDF) (10/29/21)

Moderna

Moderna is offering a webinar titled "Important Updates on the mRNA-1273 50 µg Booster Dose" for vaccination providers to learn more about the Moderna COVID-19 vaccine booster dose. Webinar times and dates are as follows:
* November 4 at 3:00 p.m. (ET) ([link removed])
* November 11 at 12:00 p.m. (ET) ([link removed] )

These Moderna COVID-19 vaccine educational materials and web pages have been updated:
* CDC: Clinical guidance and vaccine information for Moderna COVID-19 Vaccine ([link removed])
* FDA: Moderna EUA Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) including the Full EUA Prescribing Information ([link removed]) (PDF) (10/20/21)
* FDA: Vaccine Information Fact Sheet for Recipients and Caregivers Emergency Use Authorization (EUA) of the Moderna COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 18 Years of Age and Older ([link removed]) (PDF) (10/20/21)

Janssen (Johnson & Johnson)

These Janssen COVID-19 vaccine educational materials and web pages have been updated:
* CDC: Clinical guidance and vaccine information for Janssen COVID-19 Vaccine (Johnson & Johnson) ([link removed])
* FDA: Janssen EUA Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) including the Full EUA Prescribing Information ([link removed]) (PDF) (10/20/21)
* FDA: Vaccine Information Fact Sheet for Recipients and Caregivers Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 18 Years of Age and Older ([link removed]) (PDF) (10/20/21)

------------------------------------------------------------
CDC updates orders regarding COVID-19 testing and vaccination of international travelers flying to the United States, effective November 8

On October 25, the White House issued a proclamation ([link removed] ) effective November 8 that will lift the geographic travel restrictions and replace them with restrictions on entry of noncitizens who are nonimmigrants traveling to the United States by air from any part of the world unless they are fully vaccinated against COVID-19. There are some exceptions, including exceptions for children less than age 18 years.

As part of this policy change, CDC continues to require all fully vaccinated passengers to show a negative COVID-19 test performed on a specimen taken 3 days preceding their flight's departure from a foreign country traveling to the United States. For all passengers who are not fully vaccinated, the rules will tighten on November 8 ([link removed]) to require a negative test taken no more than one day before departing to the United States. All travelers are also required to wear masks while on conveyances and at transportation hubs.
[link removed]
Related Links
* CDC press release: CDC Issues Orders Operationalizing the President’s Safer, More Stringent International Travel System ([link removed]) (10/25/21)
* CDC: Order: Implementing Presidential Proclamation on Safe Resumption of Global Travel during the COVID-19 Pandemic ([link removed]) web page
* CDC: COVID-19: CDC Orders ([link removed]) main page
* The White House: Fact Sheet: Biden Administration Releases Additional Detail for Implementing a Safer, More Stringent International Air Travel System ([link removed]) (10/25/21)

Back to top (#Top)

------------------------------------------------------------
GlaxoSmithKline recalls one lot of pediatric hepatitis B vaccine pre-filled syringes for missing label on some syringes

GlaxoSmithKline is voluntarily recalling one lot of pediatric Engerix-B brand hepatitis B vaccine consisting of 10 pre-filled syringes per pack from Lot CP23D (expiration date: December 2023). This lot was shipped between June and August 2021. The recall is a precautionary measure because a small number of syringes were included in the packages without a syringe label. There is no quality issue with the pre-filled syringes or the vaccine. Vaccinations administered from the affected lot are valid and do not need to be repeated.

For more information, call the GSK Response Center at 1-888-825-5249.

------------------------------------------------------------
Keep up with influenza this season: CDC’s FluView surveillance reports now being posted weekly

Influenza season has begun. CDC expects influenza activity, which is currently low, to increase in the coming weeks or months. CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , provides a valuable snapshot of influenza activity state-by-state. Visit it regularly to stay informed about influenza in your community this season.

[link removed]

If you don’t provide influenza vaccine at your site, please strongly recommend vaccination and refer people to sites that do vaccinate. Boston Children’s Hospital, in partnership with CDC, has developed VaccineFinder, a user-friendly website to help people of all ages find influenza, COVID-19, and other vaccines ([link removed]) . Participating providers can now update their vaccine inventory estimates on VaccineFinder for a more accurate reporting. For questions or more information, contact [email protected] (mailto:[email protected]) .

Related Links
* CDC: Influenza (Flu) ([link removed]) main page
* CDC: FluView ([link removed]) main page
* IAC: free educational materials and patient handouts related to influenza ([link removed])
* IAC: Influenza: Vaccines ([link removed]) main page
* IAC: Ask the Experts: Influenza ([link removed]) main page
* VaccineFinder ([link removed]) website
* Families Fighting Flu: Flu Resources for Healthcare Professionals ([link removed]) main page

------------------------------------------------------------
IAC SPOTLIGHT! IAC’S “STANDING ORDERS TEMPLATES FOR ADMINISTERING VACCINES” MAIN PAGE OFFERS TEMPLATES TO FACILITATE VACCINE DELIVERY

Simplify vaccination in your practice by using standing orders. IAC's Standing Orders Templates for Administering Vaccines ([link removed]) main page includes 35 straightforward standing order templates that allow qualified health care professionals to assess the need for and administer vaccines to patients meeting certain criteria, such as age or underlying medical condition.

Standing orders help you increase immunization rates by enabling assessment and vaccination of the patient without the need for clinician examination or a direct order from the attending provider at the time of the interaction. Standing orders can be established for the administration of one or more specific vaccines to a broad or narrow set of patients in healthcare settings such as clinics, hospitals, pharmacies, and long-term care facilities.

[link removed]

Visit the Standing Orders Templates for Administering Vaccines ([link removed]) main page on Immunize.org to view the standing orders templates.

Related Links
* IAC: Using Standing Orders for Administering Vaccines: What You Should Know ([link removed]) (PDF)
* IAC: 10 Steps to Implementing Standing Orders for Immunization in Your Practice Setting ([link removed]) (PDF)

Back to top (#Top)

------------------------------------------------------------
Journalists interview IAC experts

Journalists seek out IAC experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a selection of our recent citations.
* CQ Researcher: COVID-19 Vaccines: Will Mandates Bring the Pandemic under Control? ([link removed]) (10/29/21)
* National Geographic: What to Expect with COVID-19 Vaccines for Kids Ages 5 to 11 ([link removed]) (10/26/21)
* AlterNet: Do You Need a COVID Booster Shot? Here's What You Should Know ([link removed]) (10/19/21)

Related Link
* IAC in the News ([link removed]) main page

------------------------------------------------------------
Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: Who Had COVID-19 Vaccine Breakthrough Cases? ([link removed]) (10/28/21)
* NBC: Why Do Kids Need the COVID Vaccine? ([link removed]) (10/28/21)
* Washington Post: Vaccine Eligibility for Mood Disorders Underscores Elevated COVID Risk ([link removed]) (10/27/21)
* New York Times: When Vaccinating Kids, Does Weight Matter? Should an 11-Year-Old Wait to Turn 12 to Get a Bigger Dose? ([link removed]) (10/26/21)
* AMA: Signs Point to a Worse Flu Season. Vaccination’s the Answer. ([link removed]) (10/26/21)
* Science Alert: Pilot Program Suggests Paying People to Get Vaxxed Might Actually Work ([link removed]) (10/26/21)


------------------------------------------------------------
CORRECTION: IAC EXPRESS # 1,597 (OCTOBER 27)

The story titled “IAC Summarizes ACIP Meeting on Pneumococcal, Zoster, and Influenza Vaccines, October 20,” summarizing the October 20 ACIP meeting, described a recent study supporting coadministration of COVID-19 vaccine and seasonal influenza vaccine and incorrectly listed the influenza vaccine in the study as Fluzone Quadrivalent (Sanofi). The vaccine in the study was Fluzone High-Dose Quadrivalent (Sanofi). The archived edition on the website has been corrected.


------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
IAC UPDATES FOUR INFLUENZA-RELATED, PRINT-READY MATERIALS FOR PATIENTS AND HEALTHCARE PERSONNEL

IAC recently updated four influenza-related handouts.

[link removed] [link removed]

IAC's Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months through 8 Years ([link removed]) and Influenza Vaccination of People with a History of Egg Allergy ([link removed]) were edited to remove reference to trivalent influenza vaccine.

Don’t Take Chances with Your Family’s Health – Make Sure You All Get Vaccinated against Influenza Every Year! ([link removed]) and Influenza: Questions and Answers ([link removed]) were edited to provide updated data on hospitalization and deaths from influenza. Additionally, Don’t Take Chances emphasizes that people infected with influenza virus may not feel sick but still can spread influenza, even before they develop symptoms. Influenza: Q & A emphasizes the timing for people to be vaccinated, and includes information on co-administration of influenza and COVID-19 vaccines.

------------------------------------------------------------
RECAP: THESE UPDATED IAC EDUCATIONAL MATERIALS FOR CLINICIANS WERE RELEASED DURING SEPTEMBER AND OCTOBER

IAC Express regularly provides readers with information about IAC’s new and updated educational materials for healthcare professionals and handouts for patients. All IAC materials are free to distribute.

In case you missed them during recent weeks, updates were made to these helpful materials:

IAC’s Updated Materials for Clinicians
* Healthcare Personnel Vaccination Recommendations ([link removed])
* Protective Measures for Vaccinating During the Pandemic ([link removed])
* Temperature logs for refrigerators available in Fahrenheit ([link removed]) or Celsius ([link removed])
* Temperature logs for freezers available in Fahrenheit ([link removed]) or Celsius ([link removed])
* Vaccine Storage Troubleshooting Record ([link removed])
* Checklist for Safe Vaccine Storage and Handling ([link removed])
* Don't Be Guilty of the Preventable Errors in Vaccine Storage and Handling! ([link removed])
* Supplies You May Need at an Immunization Clinic ([link removed])

IAC’s Updated Influenza Web Page and Materials for Clinicians
* Communicating the Benefits of Influenza Vaccine during COVID-19 ([link removed])
* Influenza Vaccine Products for the 2021–2022 Influenza Season ([link removed])
* Ask the Experts: Influenza ([link removed]) web page
* Standing Orders for Administering Influenza Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Influenza Vaccine to Adults ([link removed])
* Screening Checklist for Contraindication to Inactivated Injectable Influenza Vaccination ([link removed])
* Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed])

Related Links
* IAC:Handouts ([link removed]) main page to see educational materials sorted by category
* IAC: Ask the Experts ([link removed]) main page to access more than 1,000 questions answered by IAC experts
* IAC: Clinic Tools ([link removed]) main page and its nine subtopics
* IAC: Educational Materials for Patients and Staff ([link removed]) —an alphabetical list of more than 300 ready-to-print staff educational materials and patient handouts

------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
RECAP: THESE NEW VISS AND VIS TRANSLATIONS WERE RELEASED DURING SEPTEMBER AND OCTOBER

IAC Express regularly provides readers with information about Vaccine Information Statements (VISs) and translations of VISs.

On October 15th, CDC released updated final versions of the Hepatitis A, ([link removed]) Hepatitis B, ([link removed]) Multi-vaccine Pediatric ([link removed]) , and Rotavirus ([link removed]) VISs. Translations for these new VISs are in progress and will be posted during the month of November.

During September and October, IAC posted more than 150 translations of VISs in the following languages and you can access up-to-date VIS translations on these pages:
* Arabic ([link removed])
* Burmese ([link removed])
* Chinese (Simplified and Traditional) ([link removed])
* Dari ([link removed])
* French ([link removed])
* Pashto ([link removed])
* Russian ([link removed])
* Somali ([link removed])
* Spanish ([link removed])
* Turkish ([link removed])
* Vietnamese ([link removed])

Plus, two IAC handouts related to VISs were updated: Dates of Current Vaccine Information Statements (VISs) ([link removed]) and You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed])

Related Links
* IAC: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
* IAC: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page


------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Give thanks for COVID-19 vaccines this season! IAC offers FREE "I Got My COVID-19 Vaccine" buttons and stickers. Available in English and Spanish.

Anyone promoting COVID-19 vaccination can order IAC’s FREE “I Got My COVID-19 Vaccine” buttons and stickers ([link removed]) , provided with support from CDC. Available in English and Spanish, the buttons and stickers look great on lab coats, uniforms, jackets, lanyards, ID badges, or backpacks to show confidence in COVID-19 vaccination.

Click the picture below to go directly to the order form.

[link removed]

Related Links
* IAC: FREE "I Got My COVID-19 Vaccine" buttons and stickers order form ([link removed])
* Shop IAC ([link removed]) main page: All the buttons, stickers, laminated schedules, record cards, and other products offered by IAC

------------------------------------------------------------
EXPLORE THE UPDATED WWW.GIVE2MENACWY.ORG WEBSITE TO INCREASE COVERAGE FOR THE MENACWY BOOSTER AND OTHER ADOLESCENT VACCINATIONS

IAC’s www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including administering the recommended booster dose of MenACWY vaccine at age 16. Many teens are behind on vaccines because of the pandemic, so adolescent vaccination is more important than ever.

Original materials on this colorful website for healthcare professionals have been updated to incorporate the 2020 ACIP meningococcal vaccine recommendations ([link removed]) and the most recent vaccine coverage statistics from CDC’s National Immunization Survey–Teen (NIS–Teen). One particularly popular resource on the site is the updated Algorithm for MenACWY Immunization in Adolescents 11–18 Years of Age ([link removed]) .

[link removed]

The website’s navigation structure makes locating information a breeze; it is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]) – Teen vaccination schedules and tips for improving adolescent vaccination rates
* Give 2 Doses ([link removed]) – Tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]) – Resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]) – Tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]) – Links to print materials ([link removed]) , organizations ([link removed]) involved in adolescent vaccination, personal stories ([link removed]) about the importance of vaccination, and additional resources ([link removed]) of interest

The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.

Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.

Related Links
* Give2MenACWY.org ([link removed]) website
* Algorithm for MenACWY Immunization in Adolescents 11–18 Years of Age ([link removed])
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* You're 16: We Recommend These Vaccines for You ([link removed])
* 2020 ACIP Meningococcal Vaccine Recommendations ([link removed])
* Adolescent Vaccination Coverage in the U.S. ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]) – signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])

------------------------------------------------------------
Notable Publications
------------------------------------------------------------
"Laboratory-Confirmed COVID-19 among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity—Nine States, January–September 2021" published in MMWR Early Release

CDC published Laboratory-Confirmed COVID-19 among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity—Nine States, January–September 2021 ([link removed]) on October 29 as an MMWR Early Release. A portion of the summary appears below.

Previous infection with SARS-CoV-2 or COVID-19 vaccination can provide immunity and protection against subsequent SARS-CoV-2 infection and illness....

Among COVID-19–like illness hospitalizations among adults aged ≥18 years whose previous infection or vaccination occurred 90–179 days earlier, the adjusted odds of laboratory-confirmed COVID-19 among unvaccinated adults with previous SARS-CoV-2 infection were 5.49-fold higher than the odds among fully vaccinated recipients of an mRNA COVID-19 vaccine who had no previous documented infection....

All eligible persons should be vaccinated against COVID-19 as soon as possible, including unvaccinated persons previously infected with SARS-CoV-2.

[link removed]

Access the MMWR Early Release article in HTML ([link removed]) or PDF ([link removed]).

Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications

------------------------------------------------------------
MMWR Recap: “COVID-19 Vaccination and Non-COVID-19 Mortality Risk—Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021”

CDC recently published an article first distributed as MMWR Early Release:
* COVID-19 Vaccination and Non-COVID-19 Mortality Risk—Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 (MMWR, October 29, HTML ([link removed]) or PDF ([link removed]) )

Related Link
* MMWR ([link removed]) main page provides access to MMWR Weekly and its companion publications

------------------------------------------------------------
CHOP's Vaccine Education Center publishes October issue of Vaccine Update newsletter

The Vaccine Education Center (VEC) ([link removed]) at Children's Hospital of Philadelphia (CHOP) publishes a monthly immunization-focused newsletter titled Vaccine Update for Providers. The October issue ([link removed]) includes the following articles:
* In the Journals: A Potential Fourth COVID-19 Vaccine ([link removed]) by Paul A. Offit, MD
* Technically Speaking—When It Comes to MenACWY, Join the "We Never Guess! We Look It Up" Club ([link removed]) by Sharon G. Humiston, MD, MPH

[link removed]

Additional resources, including information booklets for patients, are available in the full newsletter ([link removed]).

Access the sign-up form ([link removed]) to subscribe to Vaccine Update for Providers.

------------------------------------------------------------
Global News
------------------------------------------------------------
“Routine Vaccination Coverage—Worldwide, 2020” published in MMWR

CDC published Routine Vaccination Coverage—Worldwide, 2020 ([link removed]) on October 29 in MMWR. A summary appears below.

After stagnating from 2010–2019, global immunization coverage for diphtheria, tetanus, and pertussis-containing vaccine (DTP) declined in 2020 to the lowest rates recorded in over a decade, likely impacted by the COVID-19 pandemic. Worldwide, 22.7 million children missed their third DTP dose. The number of “zero-dose” children, infants who do not receive the first DTP vaccine within the first year of life, increased by 3.5 million from 2019 to 2020. Of the 17.1 million zero-dose children, almost two-thirds (65%) lived in just 10 countries. Coverage for Haemophilus Influenzae type b, measles and rubella-containing vaccine, polio, hepatitis B, and HPV vaccines also declined. Swift and tailored strategies are needed to recover from immunization program interruptions, reach and vaccinate missed children, and prevent outbreaks of dangerous, vaccine-preventable diseases.

Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .

Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications

------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today! Virtual: CDC offers "Current Issues in Immunization Webinar" on recommendations for the 2021–22 influenza season on November 3

CDC will host its Current Issues in Immunization Webinar ([link removed]) to provide an update on recommendations for the 2021–22 influenza season today, November 3, from 12:00–1:00 p.m. (ET).

Attendance for the live webinar is limited to 1,500 registrants, so log in early to secure a "seat." If you miss the live event, you can watch the archived version once it is posted on CDC’s website.


------------------------------------------------------------
=VIRTUAL: VACCINE EDUCATION CENTER’S CURRENT ISSUES IN VACCINES FOR PROVIDERS WEBINAR ON DECEMBER 8 FEATURES DR. PAUL OFFIT DISCUSSING COVID-19 VACCINE BOOSTER DOSES; CE AVAILABLE=

The Vaccine Education Center (VEC) at Children's Hospital of Philadelphia will present a 1-hour webinar titled Do We Need a COVID-19 Vaccine Booster Dose? ([link removed]) beginning at 12:00 p.m. (ET) on December 8. Part of its Current Issues in Vaccines ([link removed]) series, the webinar will feature Paul Offit, MD, director of the VEC.

Free continuing-education credits (CME, CEU, and CPE) will be available for both the live and archived events.

Register for the webinar ([link removed]).

------------------------------------------------------------

For more upcoming events, visit our Calendar of Events ([link removed]).
Back to top (#Top)
[link removed]


IAC Express

IAC Express Home ([link removed])

2021 Issues: July–Dec ([link removed])

2021 Issues: Jan–June ([link removed])

2020 Issues ([link removed])

2019 Issues ([link removed])


2018 ([link removed]) – (#IACX4) 1997 Issues ([link removed])

------------------------------------------------------------

[link removed]

[link removed]

[link removed]

[link removed]

------------------------------------------------------------

[link removed]
[link removed]
------------------------------------------------------------

Follow Us

[link removed]
[link removed]

------------------------------------------------------------

Vaccinating Adults:
A Step-by-Step Guide

[link removed]

New! IAC's 142-page book available for free download ([link removed]) .

------------------------------------------------------------

Calendar of Events

[link removed]
Conferences, meetings, and training opportunities

------------------------------------------------------------

Patient Record Cards

[link removed]
Record cards for patients --child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded

------------------------------------------------------------

DVD: Immunization Techniques

[link removed]
Every practice should have this award winning, "how-to" training video

------------------------------------------------------------

Protect Newborns Guidebook
[link removed]

Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])

------------------------------------------------------------

Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John Grabenstein, RPh, PhD
Associate Editor
Sharon Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Robin VanOss
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue ([link removed]) .

IAC Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC.

IAC Express Disclaimer ([link removed])
ISSN: 1526-1786

Our mailing address:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
To unsubscribe to this publication, go to: [link removed]
==============================================

Unsubscribe [email protected] from this list:
[link removed]
Screenshot of the email generated on import

Message Analysis